Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
12,683
datasets available to search
ShareScore release 0.9.0
Dataset results
12,683 results for “tolerability”
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Doses of MOTREM (Nangibotide) in Patients With Septic Shock
ClinicalTrials.gov study NCT03158948. IPD Sharing: NO. Countries: 4. Publications: 0.
Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations
ClinicalTrials.gov study NCT04641442. IPD Sharing: YES. Countries: 7. Publications: 0.
A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink.
ClinicalTrials.gov study NCT04194645. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema
ClinicalTrials.gov study NCT04292912. IPD Sharing: YES. Countries: 3. Publications: 0.
Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations
ClinicalTrials.gov study NCT00505622. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected Patients
ClinicalTrials.gov study NCT01725529. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction
ClinicalTrials.gov study NCT01212172. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-label, Dose Escalation, Pharmacodynamic, Pharmacokinetic, and Effect of Food Phase 1 Study of E7820 to Determine the Maximum Tolerated Dose Following Twice Daily Oral Administration in Subject
ClinicalTrials.gov study NCT01773421. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study to Evaluate the Safety and Tolerability of Raxibacumab in Healthy Subjects
ClinicalTrials.gov study NCT00639678. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Immune Globulin (Human) 10% (Gamunex-C) PEG Process (IVIG-PEG) Compared to Gamunex-C in Participants With Primary Humoral Immunode
ClinicalTrials.gov study NCT04561115. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety, Tolerability and Pharmacokinetics Study of MK-7252 in Healthy Adult Participants (MK-7252-001)
ClinicalTrials.gov study NCT03326986. IPD Sharing: YES. Countries: 1. Publications: 0.
First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects
ClinicalTrials.gov study NCT05427253. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Tolerability of ONL1204 in Patients With Macula-off, Rhegmatogenous Retinal Detachment
ClinicalTrials.gov study NCT03780972. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Tolerability of Trospium Chloride and Metformin Hydrochloride in Healthy Subjects
ClinicalTrials.gov study NCT00986401. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism
ClinicalTrials.gov study NCT00282412. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 409306
ClinicalTrials.gov study NCT01611311. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)
ClinicalTrials.gov study NCT00911534. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated.
ClinicalTrials.gov study NCT03238963. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Clarithromycin Modified Release Observational Study for Evaluation of Treatment, Tolerability & Recovery Time in Saudi & Egyptian Clinical Settings (CLOSER)
ClinicalTrials.gov study NCT01075204. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension
ClinicalTrials.gov study NCT00142584. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.